India directs WhatsApp to block device IDs used in digital arrest scams. New measures to combat fraud...
India considers resuming Iranian oil imports after the US eases sanctions. Asian refiners explore options amid energy...
Indian firms launch generic semaglutide, challenging Novo Nordisk's Ozempic & Wegovy. Affordable access to diabetes & weight...
Dr. Reddy's Laboratories introduces Obeda, a semaglutide injectable, in India, enhancing their diabetes care portfolio. A new...
Dr. Reddy's Laboratories introduces 'Obeda', a semaglutide version for diabetes management in India. Aims to expand its...
Indian startups raised $228.4M across 21 deals amidst global market uncertainties. Fintech leads, followed by e-commerce. Key...
Dr. Reddy's introduces Obeda, a generic semaglutide injection, the first DCGI-approved treatment for Type 2 diabetes in...
Delhi Police seals United News of India (UNI) office following a Delhi High Court order related to...
Diesel prices surge in India due to geopolitical tensions, impacting manufacturing, logistics, and infrastructure. Industries face increased...
Can Alphabet's (GOOGL) stock reach $350 by year-end? Financial analysis examines growth, market factors, and the plausibility...